FDA Approved: APRETUDE — Supplemental Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approves a supplemental application for APRETUDE (cabotegravir) submitted by ViiV Healthcare Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• APRETUDE (CABOTEGRAVIR)

Snippet

SUPPL AP for APRETUDE (CABOTEGRAVIR)